![Simon Sturge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/05/2026
Simon John Sturge is the founder of Ligand UK Ltd., RiboTargets Ltd. Current positions include Executive Chairman at Mediar Therapeutics, Inc. since 2021, Chairman at Moonlake Immunotherapeutics AG since 2021, and Trustee at Weizmann UK.
Former roles include Chief Executive Officer & Director at Lonza Biologics Plc, Chief Executive Officer at Dr. Reddy's Research & Development BV from 2008 to 2011, Chief Executive Officer & Director at Kymab Ltd. from 2019 to 2021, Chief Executive Officer & Director at Kymab Group Ltd., Chairman-Supervisory Board at Cristal Delivery BV, Chairman at MoonLake Immunotherapeutics from 2022 to 2026, Director at Celltech Group Plc, Independent Non-Executive Director at Silence Therapeutics Plc from 2015 to 2016, Independent Non-Executive Director at Feedback Plc from 2017 to 2021, Independent Non-Executive Director at Galapagos NV from 2023 to 2025, Chief Operating Officer-Healthcare at Merck KGaA from 2013 to 2019, Manager-Business Development at Astra Pharmaceuticals Ltd., Senior Vice President at Boehringer Ingelheim BV from 2010 to 2013, and Chief Operating Officer at Merck Healthcare.
Education includes an undergraduate degree from the University of Sussex conferred in 1980.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2025 | 171.980 ( 0,23 % ) | 3 M $ | 31/05/2026 | |
| 31/12/2025 | 501 ( 0 % ) | 14 300 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Presidente | 10/08/2021 |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Presidente | 15/09/2021 |
Weizmann UK
 Weizmann UK Miscellaneous Commercial ServicesCommercial Services Operates scientific research institutes | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Presidente | 28/02/2026 |
| LAKEFRONT BIOTHERAPEUTICS NV | Director/Miembro de la Junta | 28/07/2025 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Director Ejecutivo | 01/07/2021 |
| FEEDBACK PLC | Director/Miembro de la Junta | 30/06/2021 |
| MERCK KGAA | Corporate Officer/Principal | 01/04/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 20 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Feedback Plc
 Feedback Plc Packaged SoftwareTechnology Services Develops medical imaging communications application | Technology Services |
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies | Commercial Services |
RiboTargets Ltd.
 RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Health Technology |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Health Technology |
University of Sussex
 University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra Pharmaceuticals Ltd.
 Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures & wholesales pharmaceutical products | Health Technology |
Boehringer Ingelheim BV
 Boehringer Ingelheim BV Drugstore ChainsRetail Trade Develops and markets drugs | Retail Trade |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Weizmann UK
Weizmann UK Miscellaneous Commercial ServicesCommercial Services Operates scientific research institutes | Commercial Services |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Develops and manufactures nanomedicines for therapeutic drug optimization | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Merck Healthcare | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
MoonLake Immunotherapeutics
 MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
